Article Details

Biogen reveals new data for MS therapies Tysabri and Vumerity

Retrieved on: 2021-04-22 11:03:45

Tags for this article:

Click the tags to see associated articles and topics

Biogen reveals new data for MS therapies Tysabri and Vumerity. View article details on hiswai:

Excerpt

Biogen has announced new data for its multiple sclerosis therapies Tysabri and Vumerity, including analyses of extended interval dosing (EID) and ...

Article found on: www.pmlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up